Menu

USDA Will Not Regulate CRISPR-Edited Crops

Restrictions will remain on transgenic plants, which contain artificially inserted genes from other species.

Apr 2, 2018
Diana Kwon

PIXABAY, ANALOGICUS

The US Department of Agriculture (USDA) will not regulate plants that have been modified through genome editing, according to statement released last week (March 28) by the agency.

In the announcement, the USDA states that it won’t oversee the use of genetically altered plants, as long as they could have also been developed through traditional breeding methods, such as cross-breeding or selecting for desirable properties. The agency adds that genome editing allows breeders to introduce new traits more precisely, and at a faster rate.

“With this approach, USDA seeks to allow innovation when there is no risk present,” US Secretary of Agriculture Sonny Perdue says in the statement. “Plant breeding innovation holds enormous promise for helping protect crops against drought and diseases while increasing nutritional value and eliminating allergens.” 

MIT Technology Review notes that transgenic crops—plants that contain artificially inserted genes from other species—will still be regulated.

See “The Unregulation of Biotech Crops

This announcement comes as good news to biotech companies using CRISPR to modify plants. According to Wired, this move will “[shave] years and tens of millions of dollars off the cost of developing a designer plant.”

“Having this consistent position enables smaller companies and academic labs to form this ecosystem of innovation to bring options to consumers,” Federico Tripodi, CEO of Calyxt, a Minnesota-based biotech that has already developed soybeans that produce oil low in trans fats that can be cooked at high heat, tells Wired.  

Whether gene-edited plants require special labeling is still unclear. “Bioengineered foods are defined by containing genetic material that could not otherwise have been conventionally bred or obtained in nature,” Deepti Kulkarni, a former member of the FDA’s Office of Chief Counsel who currently works at Sidley Austin, a corporate law firm in the U.S., tells Wired. “If USDA is construing the language this way, there is some suggestive signaling that these products might not be subject to disclosure.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.